Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-76fb5796d-9pm4c Total loading time: 0 Render date: 2024-04-28T11:19:18.426Z Has data issue: false hasContentIssue false

Section 1 - Cardiovascular System

from Part 3 - Systems Based Overview of Cancer Complications

Published online by Cambridge University Press:  10 August 2023

Monica Kathleen Wattana
Monica Kathleen Wattana
Affiliation:
University of Texas, MD Anderson Cancer Center
Get access

Summary

Overview of cardiac complicationsincluding arrhythimias, heart failure, acute coronary syndrome, disseminated intravascular coagulation, hyperviscosity syndrome, and pulmonary embolism

Keywords

cardiovascularpulmonary embolismarrhythmiablood transfusioncarotid blowoutpericarditis
Type
Chapter
Information
Pocket Guide to Oncologic Emergencies , pp. 43 - 96
Publisher: Cambridge University Press
Print publication year: 2023

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

References

Barber, M, Nguyen, LS, Wassermann, J, Spano, J-P, Funck-Brentano, C, Salem, J-E. Cardiac arrhythmia considerations of hormone cancer therapies. Cardiovascular Research. 2019 Jan 30;115(5):878–894.Google Scholar
Gevaert, SA, Halvorsen, S, Sinnaeve, PR, Sambola, A, Gulati, G, Lancellotti, P, Van Der Meer, P, Lyon, AR, Farmakis, D, Lee, G, Boriani, G, Wechalekar, A, Okines, A, Asteggiano, R. Evaluation and management of cancer patients presenting with acute cardiovascular disease: A consensus document of the Acute CardioVascular Care (ACVC) Association and the ESC Council of Cardio-Oncology. Part 1: Acute coronary syndromes and acute pericardial diseases. European Heart Journal Acute Cardiovascular Care. 2021 Aug 28;10(8):947–959.CrossRefGoogle ScholarPubMed
Herrmann, J. Adverse cardiac effects of cancer therapies: Cardiotoxicity and arrhythmia. Nature Reviews Cardiology. 2020 Mar 30;17(8):474–502.CrossRefGoogle ScholarPubMed

References

Asteggiano, R, Norbiato, C, Marengo, S, Parrini, I. Cancer and arrhythmias. e-Journal of Cardiology Practice. 2021 May;19(21).Google Scholar
Buza, V, Rajagopalan, B, Curtis, AB. Cancer treatment–induced arrhythmias. Circulation: Arrhythmia and Electrophysiology. 2017 Aug;10(8):52.Google Scholar
Herrmann, J. Adverse cardiac effects of cancer therapies: Cardiotoxicity and arrhythmia. Nature Reviews Cardiology. 2020 Mar 30;17(8):474–502.CrossRefGoogle ScholarPubMed
Porta‐Sánchez, A, Gilbert, C, Spears, D, Amir, E, Chan, J, Nanthakumar, K, Thavendiranathan, P. Incidence, diagnosis, and management of QT prolongation induced by cancer therapies: A systematic review. Journal of the American Heart Association. 2017 Dec 2;6(12): e007724.Google Scholar
Viganego, F, Singh, R, Fradley, MG. Arrhythmias and other electrophysiology issues in cancer patients receiving chemotherapy or radiation. Current Cardiology Reports. 2016 Apr 23;18(6): 52.Google Scholar
Zhu, T, Enriquez, A, Baranchuk, A. Cancer and cancer therapy and their association with ventricular arrhythmia. Canadian Journal of Cardiology. 2017 Feb;33(2):293.e11.Google Scholar

References

Al-Hawwas, M, Tsitlakidou, D, Gupta, N, Iliescu, C, Cilingiroglu, M, Marmagkiolis, K. Acute coronary syndrome management in cancer patients. Current Oncology Reports. 2018 Aug 22;20(10).CrossRefGoogle ScholarPubMed
Bharadwaj, A, Potts, J, Mohamed, MO, Parwani, P, Swamy, P, Lopez-Mattei, JC, Rashid, M, Kwok, CS, Fischman, DL, Vassiliou, VS, Freeman, P, Michos, ED, Mamas, MA. Acute myocardial infarction treatments and outcomes in 6.5 million patients with a current or historical diagnosis of cancer in the USA. European Heart Journal. 2019 Dec 4;41(23):2183–2193.CrossRefGoogle Scholar
Bisceglia, I, Canale, ML, Lestuzzi, C, Parrini, I, Russo, G, Colivicchi, F, Gabrielli, D, Gulizia, MM, Iliescu, CA. Acute coronary syndromes in cancer patients. Journal of Cardiovascular Medicine. 2020 Jun 8;21(12):944–952.Google Scholar
Gevaert, SA, Halvorsen, S, Sinnaeve, PR, Sambola, A, Gulati, G, Lancellotti, P, Van Der Meer, P, Lyon, AR, Farmakis, D, Lee, G, Boriani, G, Wechalekar, A, Okines, A, Asteggiano, R. Evaluation and management of cancer patients presenting with acute cardiovascular disease: A consensus document of the Acute CardioVascular Care (ACVC) Association and the ESC Council of Cardio-Oncology. Part 1: Acute coronary syndromes and acute pericardial diseases. European Heart Journal Acute Cardiovascular Care. 2021 Aug 28;10(8):947–959.CrossRefGoogle ScholarPubMed
Han, X, Li, J, Khannanova, Z, Li, Y. Optimal management of coronary artery disease in cancer patients. Chronic Diseases and Translational Medicine. 2019 Dec;5(4):221–233.Google Scholar
Herrmann, J. Adverse cardiac effects of cancer therapies: Cardiotoxicity and arrhythmia. Nature Reviews Cardiology. 2020 Mar 30;17(8):474–502.CrossRefGoogle ScholarPubMed
Masson, R, Manthripragada, G, Liu, R, Tavakoli, J, Mok, K. Possible precipitation of acute coronary syndrome with immune checkpoint blockade: A case report. The Permanente Journal. 2020 Dec;24(5). Doi: 10.7812/TPP/20.037.Google Scholar
Yetis Sayin, B, Oto, MA. Acute coronary syndrome in cancer patients. American Journal of Cardiovascular Drugs. 2018 Jun 22;18(5):361–372.Google Scholar
Yusuf, SW, Daraban, N, Abbasi, N, Lei, X, Durand, J-B, Daher, IN. Treatment and outcomes of acute coronary syndrome in the cancer population. Clinical Cardiology. 2012 May 15;35(7):443–450.Google Scholar

References

AABB. AABB Quick Reference Guide for NHSN Hemovigilance Module: Adverse Reaction Definitions. Available at: www.aabb.org/docs/default-source/default-document-library/resources/aabb-quick-reference-guide-nhsn-hemovigilance-module.pdf?sfvrsn=30f1600b_4Google Scholar
Delaney, M, Wendel, S, Bercovitz, RS, Cid, J, Cohn, C, Dunbar, NM, Apelseth, TO, Popovsky, M, Stanworth, SJ, Tinmouth, A, Van De, Watering L, Waters, JH, Yazer, M, Ziman, A; Biomedical Excellence for Safer Transfusion (BEST) Collaborative. Transfusion reactions: Prevention, diagnosis, and treatment. The Lancet. 2016;388(10061):2825‒2836. Doi: 10.1016/S0140–6736(15)01313-6.Google Scholar
Federici, AB, Vanelli C, Arrigoni L. Transfusion issues in cancer patients. Thrombosis Research. 2012;129(suppl. 1):S60–S65. Doi: 10.1016/S0049–3848(12)70018-X.CrossRefGoogle ScholarPubMed
Kenz, HE, Van der Linden, P. Transfusion-related acute lung injury. European Journal of Anaesthesiology. 2014 Jul;31(7):345–350.Google Scholar
Panch, SR, Montemayor-Garcia, C, Klein, HG. Hemolytic transfusion reactions. The New England Journal of Medicine. 2019;381(2):150‒162. Doi: 10.1056/NEJMra1802338.CrossRefGoogle ScholarPubMed
Semple, JW, Rebetz, J, Kapur, R. Transfusion-associated circulatory overload and transfusion-related acute lung injury. Blood. 2019;133(17):1840‒1853. Doi: 10.1182/blood-2018-10-860809.CrossRefGoogle ScholarPubMed
Wechsler, A. Transfusions in Oncologic Emergencies [PowerPoint slides] August 25, 2022. Emergency Department, UT MD Anderson Cancer Center.Google Scholar

References

Alterio, D, Turturici, I, Volpe, S, Ferrari, A, Russell-Edu, SW, Vischioni, B, Mardighian, D, Preda, L, Gandini, S, Marvaso, G, Augugliaro, M, Durante, S, Arculeo, S, Patti, F, Boccuzzi, D, Casbarra, A, Starzynska, A, Santoni, R, Jereczek-Fossa, BA. Carotid blowout syndrome after reirradiation for head and neck malignancies: A comprehensive systematic review for a pragmatic multidisciplinary approach. Critical Reviews in Oncology/Hematology. 2020 Nov;155:103088. Doi: 10.1016/critrevonc.2020.103088.CrossRefGoogle ScholarPubMed
Lipe, DN, Viets-Upchurch, J, Hanna, EY, Reyes-Gibby, C, Chen, SR, Elsayem, A, Long, B. Carotid blowout syndrome in the Emergency Department: A case report and review of the literature. The Journal of Emergency Medicine. 2022;62(3):e29‒e34. Doi: 10.1016/j.jemermed.2021.11.009.Google Scholar

References

Levi, M. Disseminated intravascular coagulation in cancer: An update. Seminars in Thrombosis and Hemostasis. 2019 Apr 30;45(04):342–347.Google ScholarPubMed
Thachil, J, Falanga, A, Levi, M, Liebman, H, Di Nisio, M. Management of cancer-associated disseminated intravascular coagulation: Guidance from the SSC of the ISTH: Reply. Journal of Thrombosis and Haemostasis. 2015 Apr 30;13(7):1352–1353.Google Scholar

References

Bando, S, Soeki, T, Matsuura, T, Tobiume, T, Ise, T, Kusunose, K, Yamaguchi, K, Yagi, S, Fukuda, D, Iwase, T, Yamada, H, Wakatsuki, T, Shimabukuro, M, Muguruma, N, Takayama, T, Kishimoto, I, Kangawa, K, Sata, M. Plasma brain natriuretic peptide levels are elevated in patients with cancer. PLOS ONE. 2017 Jun 1;12(6):e0178607.Google Scholar
Chang, H-M, Moudgil, R, Scarabelli, T, Okwuosa, TM, Yeh, ETH. Cardiovascular complications of cancer therapy. Journal of the American College of Cardiology. 2017 Nov;70(20):2536–2551.Google Scholar
Cuomo, A, Rodolico, A, Galdieri, A, Russo, M, Campi, G, Franco, R, Bruno, D, Aran, L, Carannante, A, Attanasio, U, Tocchetti, CG, Varricchi, G, Mercurio, V. Heart failure and cancer: Mechanisms of old and new cardiotoxic drugs in cancer patients. Cardiac Failure Review. 2019 May 24;5(2):112–118.CrossRefGoogle ScholarPubMed
Finke, D, Heckmann, MB, Frey, N, Lehmann, LH. Cancer: A major cardiac comorbidity with implications on cardiovascular metabolism. Frontiers in Physiology. 2021 Nov 26;12. Doi: 10.3389/fphys.2021.729713.CrossRefGoogle Scholar
Fraley, C, Milgrom, SA, Kondapalli, L, Taylor, MRG, Mestroni, L, Miyamoto, SD. Mechanisms and insights for the development of heart failure associated with cancer therapy. Children. 2021 Sep 21;8(9):829.CrossRefGoogle ScholarPubMed
Kamai, T, Tokura, Y, Uematsu, T, Sakamoto, K, Suzuki, I, Takei, K, Narimatsu, T, Kambara, T, Yuki, H, Betsunoh, H, Abe, H, Fukabori, Y, Yashi, M, Yoshida, K-I. Elevated serum levels of cardiovascular biomarkers are associated with progression of renal cancer. Open Heart. 2018 Jan;5(1):e000666.Google Scholar
Nakao, S, Vaillancourt, C, Taljaard, M, Nemnom, M-J, Woo, MY, Stiell, IG. Diagnostic accuracy of lung point-of-care ultrasonography for acute heart failure compared with chest X-ray study among dyspneic older patients in the Emergency Department. The Journal of Emergency Medicine. 2021 Aug;61(2):161–168.CrossRefGoogle ScholarPubMed
Pai, VB, Nahata, MC. Cardiotoxicity of chemotherapeutic agents. Drug Safety. 2000;22(4):263–302.Google Scholar
Peacock, WF, Cannon, CM, Singer, AJ, Hiestand, BC. Considerations for initial therapy in the treatment of acute heart failure. Critical Care. 2015 Dec;19(1). Doi: 10.1186/s13054-015-1114-3.CrossRefGoogle ScholarPubMed
Pudil, R, Mueller, C, Čelutkienė, J, Henriksen, PA, Lenihan, D, Dent, S, Barac, A, Stanway, S, Moslehi, J, Suter, TM, Ky, B, Štěrba, M, Cardinale, D, Cohen-Solal, A, Tocchetti, CG, Farmakis, D, Bergler-Klein, J, Anker, MS, Von Haehling, S, Belenkov, Y, Iakobishvili, Z, Maack, C, Ciardiello, F, Ruschitzka, F, Coats, AJS, Seferovic, P, Lainscak, M, Piepoli, MF, Chioncel, O, Bax, J, Hulot, J-S, Skouri, H, Hägler-Laube, ES, Asteggiano, R, Lopez, Fernandez T, de Boer, RA, Lyon, AR. Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: A position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology. European Journal of Heart Failure. 2020 Nov;22(11):1966–1983. Doi: 10.1002/ejhf.2017. Epub 2020 Oct 20. PMID: 33006257.CrossRefGoogle Scholar
Silvers, SM, Howell, JM, Kosowsky, JM, Rokos, IC, Jagoda, AS. Clinical policy: Critical issues in the evaluation and management of adult patients presenting to the emergency department with acute heart failure syndromes. Annals of Emergency Medicine. 2007 May;49(5):627–669.Google Scholar

References

Higdon, ML, Atkinson, CJ, Lawrence, KV. Oncologic emergencies: Recognition and initial management. American Family Physician. 2018;97(11):741‒748.Google Scholar
Lewis, MA, Hendrickson, AW, Moynihan, TJ. Oncologic emergencies: Pathophysiology, presentation, diagnosis, and treatment. CA: A Cancer Journal for Clinicians. 2011;61(5):287‒314. Doi: 10.3322/caac.20124.Google ScholarPubMed
Perez Rogers, A, Estes, M. Hyperviscosity syndrome. StatPearls, StatPearls Publishing, Apr 30, 2022. Available at: www.ncbi.nlm.nih.gov/books/NBK518963/Google Scholar
Weaver, A, Rubinstein, S, Cornell, RF. Hyperviscosity syndrome in paraprotein secreting conditions including Waldenstrom macroglobulinemia. Frontiers in Oncology. 2020 May 19; 10(815). Doi: 10.3389/fonc.2020.00815.Google Scholar

References

Gevaert, SA, Halvorsen, S, Sinnaeve, PR, Sambola, A, Gulati, G, Lancellotti, P, Van Der Meer, P, Lyon, AR, Farmakis, D, Lee, G, Boriani, G, Wechalekar, A, Okines, A, Asteggiano, R. Evaluation and management of cancer patients presenting with acute cardiovascular disease: A consensus document of the Acute CardioVascular Care (ACVC) association and the ESC council of Cardio-Oncology – Part 1: Acute coronary syndromes and acute pericardial diseases. European Heart Journal Acute Cardiovascular Care. 2021 Aug 28;10(8):947–959.Google Scholar
Hanson, MG, Chan, B. The role of point-of-care ultrasound in the diagnosis of pericardial effusion: A single academic center retrospective study. The Ultrasound Journal. 2021;13 :2. Doi: 10.1186/s13089-021-00205.Google Scholar
Maisch, B, Ristic, A, Pankuweit, S. Evaluation and management of pericardial effusion in patients with neoplastic disease. Progress in Cardiovascular Diseases. 2010 Sep;53(2):157–163.CrossRefGoogle ScholarPubMed
Shenoy, S, Shetty, S, Lankala, S, Anwer, F, Yeager, A, Adigopula, S. Cardiovascular oncologic emergencies. Cardiology. 2017;138(3):147–158.Google Scholar

References

Altan, M, Toki, MI, Gettinger, SN, Carvajal-Hausdorf, DE, Zugazagoitia, J, Sinard, JH, Herbst, RS, Rimm, DL. Immune checkpoint inhibitor-associated pericarditis. Journal of Thoracic Oncology. 2019 Jun;14(6):1102–1108.CrossRefGoogle ScholarPubMed
Chahine, J, Shekhar, S, Mahalwar, G, Imazio, M, Collier, P, Klein, A. Pericardial involvement in cancer. The American Journal of Cardiology. 2021 Apr;145:151–159.Google Scholar
Kelleni, MT, Abdelbasset, M. Drug induced cardiotoxicity: Mechanism, prevention and management, in Cardiotoxicity [Internet]. InTech; 2018 [cited 2022 Aug 2]. Doi: 10.5772/intechopen.79611.CrossRefGoogle Scholar
Shenoy, S, Shetty, S, Lankala, S, Anwer, F, Yeager, A, Adigopula, S. Cardiovascular oncologic emergencies. Cardiology. 2017;138(3):147–158.Google Scholar
Søgaard, KK, Farkas, DK, Ehrenstein, V, Bhaskaran, K, Bøtker, HE, Sørensen, HT. Pericarditis as a marker of occult cancer and a prognostic factor for cancer mortality. Circulation. 2017 Sep 12;136(11):996–1006.CrossRefGoogle Scholar

References

Rice, TW, Rodriguez, RM, Light, RW. The superior vena cava syndrome: Clinical characteristics and evolving etiology. Medicine (Baltimore). 2006 Jan;85(1):37‒42. Doi: 10.1097/01.md.0000198474.99876.f0. PMID: 16523051.Google Scholar
Talapatra, K, Panda, S, Goyle, S, Bhadra, K, Mistry, R. Superior vena cava syndrome: A radiation oncologist’s perspective. Journal of Cancer Research and Therapeutics. 2016 Apr‒Jun;12(2):515‒519. Doi: 10.4103/0973-1482.177503. PMID: 27461602.Google Scholar
Wan, JF, Bezjak, A. Superior vena cava syndrome. Emergency Medical Clinics of North America. 2009 May;27(2):243‒255. Doi: 10.1016/j.emc.2009.01.003. PMID: 19447309.Google Scholar

References

Abdol, Razak NB, Jones, G, Bhandari, M, Berndt, MC, Metharom, P. Cancer-associated thrombosis: An overview of mechanisms, risk factors, and treatment. Cancers 2018 Oct 11;10:380. Doi: 10.3390/cancers10100380.Google Scholar
Adult Venous Thromboembolism (VTE) Treatment for Cancer Patients (DVT and PE) Clinical Algorithm MD Anderson Cancer Center. www.mdanderson.org/content/dam/mdanderson/documents/for-physicians/algorithms/clinical-management/clin-management-vte-treatment-web-algorithm.pdfGoogle Scholar
Cohen, AT, Katholing, A, Rietbrock, S, Bamber, L, Martinez, C. Epidemiology of first and recurrent venous thromboembolism in patients with active cancer. A population-based cohort study. Thrombosis and Haemostasis 2017;117(1): 57‒65. Doi: 10.1160/TH15–08-0686.Google Scholar
Cronin-Fenton, DP, Søndergaard, F, Pedersen, LA, Fryzek, JP, Cetin, K, Acquavella, J, Baron, JA, Sørensen, HT. Hospitalisation for venous thromboembolism in cancer patients and the general population: A population-based cohort study in Denmark, 1997‒2006. British Journal of Cancer 2010;103(7):947‒953. Doi: 10.1038/sj.bjc.6605883.Google Scholar
De Martino, RR, Goodney, PP, Spangler, EL, Wallaert, JB, Corriere, MA, Rzucidlo, EM, Walsh, DB, Stone, DH. Variation in thromboembolic complications among patients undergoing commonly performed cancer operations.Journal of Vascular Surgery 2012;55(4):1035‒1040.e4. Doi: 10.1016/j.jvs.2011.10.129.Google Scholar
Long, B, Koyfman, A. Oncologic emergencies: Too much clotting-venous thromboembolism in malignancy. The Journal of Emergency Medicine 2019; 57(6):825‒835. Doi: 10.1016/j.jemermed.2019.08.010.CrossRefGoogle ScholarPubMed
Mulder, FI, Candeloro, M, Kamphuisen, PW, Di Nisio, M, Bossuyt, PM, Guman, N, Smit, K, Büller, HR, van Es, N; CAT-prediction collaborators. The Khorana score for prediction of venous thromboembolism in cancer patients: A systematic review and meta-analysis. Haematologica 2019;104(6):1277‒1287. Doi: 10.3324/haematol.2018.209114.Google Scholar
Ribic, C, Crowther, M. Thrombosis and anticoagulation in the setting of renal or liver disease. Hematology. American Society of Hematology. Education Program 2016;2016(1):188‒195. Doi: 10.1182/asheducation-2016.1.188.CrossRefGoogle ScholarPubMed
Tafur, A. A low Wells score and a negative D-dimer was not safe in patients with cancer for ruling out DVT. Evidence-Based Medicine 2014;19(5):188. Doi: 10.1136/eb-2014-110014.Google Scholar
van Es, N, van der Hulle, T, van Es, J, den Exter, PL, Douma, RA, Goekoop, RJ, Mos, IC, Garcia, JG, Kamphuisen, PW, Huisman, MV, Klok, FA, Büller, HR, Bossuyt, PM. PO-07 – Excluding pulmonary embolism in cancer patients using the Wells rule and age-adjusted D-dimer testing: An individual patient data meta-analysis. Thrombosis Research 2016;140 Suppl 1:S179. Doi: 10.1016/S0049–3848(16)30140-2.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×